Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00684164
Recruitment Status : Withdrawn (Unable to complete a contract with the Sponsor)
First Posted : May 26, 2008
Last Update Posted : March 6, 2015
Astellas Pharma Inc
Information provided by:
Columbia University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2009
Estimated Study Completion Date : June 2010